Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
Development of the Heart01:27

Development of the Heart

The development of the human heart, a crucial organ, commences from the mesoderm on the 18th or 19th day after fertilization. This process initiates in the cardiogenic area, a group of mesodermal cells at the embryo's head end, which evolves into elongated strands known as cardiogenic cords. These cords undergo a transformation to form hollow-centered endocardial tubes.
As the embryo undergoes lateral folding, these paired tubes approach each other, merging into a single primitive heart tube by...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Modular cardiac microtissues for interrogating cell-type contributions.

Nature reviews. Cardiology·2026
Same author

Frataxin deficiency drives cardiac dysfunction and transcriptional dysregulation in Friedreich ataxia iPSC model.

Cell death & disease·2026
Same author

Long-read sequencing-based atlas of tissue-specific expression of DNM1L transcript variants.

The FEBS journal·2026
Same author

Hypoxia Modulates Nanovesicle Phenotype and Angiogenic Function From Human Pluripotent Stem Cells.

Proteomics·2026
Same author

Friedreich ataxia transcriptomic dysregulation and identification of cell type-specific biomarkers: A systematic review and meta-analysis.

bioRxiv : the preprint server for biology·2026
Same author

Retraction notice to "Generation of a gene-corrected human isogenic iPSC line from an Alzheimer's disease iPSC line carrying the PSEN1 H163R mutation" [Stem Cell Res. 79 (2024) 103495].

Stem cell research·2026
Same journal

SGLT2 Inhibitors and Progression of Chronic Kidney Disease in Patients with Elevated Lipoprotein(a): A Real-World Cohort Study.

Journal of cardiovascular pharmacology·2026
Same journal

Aspirin in primary prevention: a case for selective use.

Journal of cardiovascular pharmacology·2026
Same journal

GLP-1 Gene Therapy Trial for Obesity and Type 2 Diabetes: Towards a New Paradigm for Chronic Disease Treatment.

Journal of cardiovascular pharmacology·2026
Same journal

Expert Opinion: Restrictions, Precautions, or Normalcy? Defining Everyday Risk in Patients Treated With IL-1 Blockers for Recurrent Pericarditis.

Journal of cardiovascular pharmacology·2026
Same journal

The Therapeutic Role of Exercise in Diabetic Cardiomyopathy: Underlying Mechanisms and Interactions with Antidiabetic Medications.

Journal of cardiovascular pharmacology·2026
Same journal

Cardiovascular Adverse Events Associated with Immune Checkpoint Inhibitors from the Perspective of Gut Microecology: Potential Roles and Research Advances of the Gut Microbiota.

Journal of cardiovascular pharmacology·2026
See all related articles

Related Experiment Video

Updated: May 9, 2026

Generation of First Heart Field-like Cardiac Progenitors and Ventricular-like Cardiomyocytes from Human Pluripotent Stem Cells
08:37

Generation of First Heart Field-like Cardiac Progenitors and Ventricular-like Cardiomyocytes from Human Pluripotent Stem Cells

Published on: June 19, 2018

Growing vascularized heart tissue from stem cells.

Shiang Y Lim1, Damián Hernández, Gregory J Dusting

  • 1O'Brien Institute, Victoria, Australia.

Journal of Cardiovascular Pharmacology
|August 9, 2013
PubMed
Summary
This summary is machine-generated.

Cardiac tissue engineering using human stem cells shows promise for heart repair. Developing vascularized constructs is key to overcoming cell loss and advancing transplantation therapies.

More Related Videos

Generation of Aligned Functional Myocardial Tissue Through Microcontact Printing
11:09

Generation of Aligned Functional Myocardial Tissue Through Microcontact Printing

Published on: March 19, 2013

Related Experiment Videos

Last Updated: May 9, 2026

Generation of First Heart Field-like Cardiac Progenitors and Ventricular-like Cardiomyocytes from Human Pluripotent Stem Cells
08:37

Generation of First Heart Field-like Cardiac Progenitors and Ventricular-like Cardiomyocytes from Human Pluripotent Stem Cells

Published on: June 19, 2018

Generation of Aligned Functional Myocardial Tissue Through Microcontact Printing
11:09

Generation of Aligned Functional Myocardial Tissue Through Microcontact Printing

Published on: March 19, 2013

Area of Science:

  • Regenerative Medicine
  • Biomaterials Science
  • Cardiovascular Research

Background:

  • Stem cell transplantation for cardiac repair faces challenges due to significant cell loss post-transplantation.
  • Existing methods struggle to maintain viability in clinically relevant volumes of engineered cardiac tissue.
  • Vascularization and perfusion are critical for the survival and function of engineered cardiac constructs.

Purpose of the Study:

  • To describe advances in engineering vascularized and functional cardiac tissue from human stem cells.
  • To explore strategies for overcoming cell loss and improving the viability of engineered cardiac constructs.
  • To move closer to clinical applications of engineered cardiac tissues for heart repair.

Main Methods:

  • Utilizing human stem cells for generating cardiomyocytes and vascular cells.
  • Employing cardiac tissue engineering principles, including scaffold selection and culture conditions.
  • Implementing crucial strategies for achieving full vascularization and perfusion of engineered constructs.
  • Investigating the paracrine activity of stem cells to promote regeneration and neovascularization.

Main Results:

  • Demonstrated progress in growing vascularized and functional cardiac constructs using human stem cells.
  • Highlighted the potential of autologous stem cells to avoid antirejection therapies.
  • Showcased stem cell paracrine activity in stimulating endogenous repair mechanisms.
  • Reported successful transplantation of thin cardiac constructs in rat models.

Conclusions:

  • Engineering vascularized cardiac tissue from human stem cells is a viable strategy for cardiac repair.
  • Further research is needed to address challenges in scaling up constructs for clinical human transplantation.
  • Advances bring the field closer to developing engineered cardiac tissues for pacemakers, conducting tissues, or contractile myocardial flaps.